LENVIMA® (lenvatinib) HCP Website | Overall Survival (OS)
Trial Outcome Measures | Download Table
Patient-Reported Outcome Measures Used in Routine Care Predict for Survival at Disease Progression in Patients With Advanced Lung Cancer - Clinical Lung Cancer
Drug Trials Snapshot: LONSURF | FDA
Figure 3-2, Outcome Measures Framework - Tools and Technologies for Registry Interoperability, Registries for Evaluating Patient Outcomes: A User's Guide, 3rd Edition, Addendum 2 - NCBI Bookshelf
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma | NEJM
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Secondary outcome measure. The median follow-up of 15.7 months. The... | Download Scientific Diagram
Overexpression of H-Ryk in Epithelial Ovarian Cancer: Prognostic Significance of Receptor Expression | Clinical Cancer Research
Checkmate 9LA 1L NSCLC Efficacy Data | OPDIVO® (nivolumab) + YERVOY® (ipilimumab)
Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink
LENVIMA® (lenvatinib) HCP Website | Clinical Study Design
Prioritizing Patient Preferences for Ovarian Cancer Treatment | Duke Health Referring Physicians
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
Patient-Reported Outcome Measures Used in Routine Care Predict for Survival at Disease Progression in Patients With Advanced Lung Cancer - Clinical Lung Cancer
Bavencio HCP UC Efficacy
LENVIMA® (lenvatinib) HCP Website | Overall Survival (OS)
Articles Archives - Page 2 of 10 - GNS
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine
Evaluating eligibility criteria of oncology trials using real-world data and AI | Nature
JCI Insight - A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia
Event-free and overall survival of all eligible patients on the study. | Download Scientific Diagram
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health
